Tusker Minerals secures 100% of Yaoundé West Rutile Project
Tusker Minerals (ASX:TSK) has finalised the acquisition of a 100% interest in the Yaoundé West Rutile tenement package.
Every story in this category, newest first.
Tusker Minerals (ASX:TSK) has finalised the acquisition of a 100% interest in the Yaoundé West Rutile tenement package.
Cheap as Chips, a discount retailer owned by private equity firm Alceon, has been placed into administration and is poised to be acquired by rival Choice The Discount Store.
Flagship Minerals (ASX:FLG) has received the second $1.3 million strategic investment tranche from global engineering, procurement and construction group Shandong Xinhai Mining Technology & Equipment.
Media entrepreneur Antony Catalano says loss-making View Media Group remains on track for a potential initial public offering in 2027.
Cyclone Metals (ASX:CLE) has identified new gold exploration targets across its wholly owned Waikerikeri (PP60708) and Drybread (PP60707) prospecting permits in Central Otago, New Zealand.
Robex Resources (ASX:RXR) said its shareholders have overwhelmingly approved a proposed merger with Predictive Discovery (ASX:PDI).
Hundreds of Australians have suffered heavy losses after the Federal Court ordered the liquidation of NGS Crypto and related entities for operating without a financial services licence.
Australia has rolled out mandatory age verification for search engines as Ireland pushes similar rules in Europe and the United States warns the measures threaten online privacy and free speech.
MSBforSale.com has partnered with B2Vault to offer institutional-grade crypto custody alongside its MSB licensing and compliance services.
Austin Metals (ASX:AYT) reported progress on its BIF-hosted gold targeting at the Brunswick Hill prospect.
Cazaly Resources (ASX:CAZ) has entered into an agreement with Dundas Minerals (ASX:DUN) under which Dundas will earn up to an 80% interest in Cazaly's non-core Romano greenfields gold exploration project.
Arovella Therapeutics (ASX:ALA) has filed an Investigational New Drug application with the US Food and Drug Administration for ALA-10.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy